What indicates a formulation is not production-ready even after approval?
Direct Answer
A formulation is not production-ready after approval when hidden instability, scale-up mismatch, filling variation, or batch inconsistency appears under manufacturing conditions.
Decision Interpretation
Formula approval should be separated from production readiness. A formula can meet sample expectations while still failing the requirements of repeatable manufacturing.
The focus is hidden instability, which means the sample result must be translated into a manufacturing decision before the project moves closer to procurement readiness.
Manufacturing Risk Framing
Signals include texture breakdown, separation, viscosity shift, poor filling flow, delayed packaging interaction, inconsistent batches, or sensitivity to heat, shear, pressure, or storage.
This risk should be reviewed as part of the sample-to-production bridge, where sample evidence is tested against actual production constraints.
What to evaluate next
The next decision is to determine whether the formulation needs adjustment or whether production conditions can be modified without creating new risk.
The purpose is to decide the manufacturing direction, not to treat the sample result as a final commercial decision.
Decision System Link
Decision Closure Layer
This page belongs to the sample-to-procurement bridge because it converts sample-stage evidence into manufacturing decision direction before procurement readiness is assumed.
No sample result should be interpreted alone. It should be checked against scale-up risk, packaging compatibility, filling behavior, stability expectations, and production readiness boundaries.